[go: up one dir, main page]

EE200000384A - Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool - Google Patents

Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool

Info

Publication number
EE200000384A
EE200000384A EEP200000384A EEP200000384A EE200000384A EE 200000384 A EE200000384 A EE 200000384A EE P200000384 A EEP200000384 A EE P200000384A EE P200000384 A EEP200000384 A EE P200000384A EE 200000384 A EE200000384 A EE 200000384A
Authority
EE
Estonia
Prior art keywords
propoxyphenoxy
isopropylmethyl
amine
ethyl
phosphate salt
Prior art date
Application number
EEP200000384A
Other languages
English (en)
Estonian (et)
Inventor
Horvath Karol
Larsson Ulf
Sandberg Rune
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000384A publication Critical patent/EE200000384A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000384A 1997-12-22 1998-12-15 Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool EE200000384A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704835A SE9704835D0 (sv) 1997-12-22 1997-12-22 New compound
PCT/SE1998/002316 WO1999032431A1 (fr) 1997-12-22 1998-12-15 Nouveau phosphate d'isopropylmethyl-[2-(3-n-propoxyphenoxy)ethyl]amine

Publications (1)

Publication Number Publication Date
EE200000384A true EE200000384A (et) 2001-12-17

Family

ID=20409538

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000384A EE200000384A (et) 1997-12-22 1998-12-15 Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool

Country Status (22)

Country Link
US (1) US6235792B1 (fr)
EP (1) EP1047663A1 (fr)
JP (1) JP2001526254A (fr)
KR (1) KR20010033407A (fr)
CN (1) CN1280559A (fr)
AR (1) AR017199A1 (fr)
AU (1) AU1989299A (fr)
BR (1) BR9814381A (fr)
CA (1) CA2314989A1 (fr)
EE (1) EE200000384A (fr)
HU (1) HUP0004428A3 (fr)
ID (1) ID26940A (fr)
IL (1) IL136829A0 (fr)
IS (1) IS5544A (fr)
NO (1) NO20003216D0 (fr)
PL (1) PL341525A1 (fr)
SE (1) SE9704835D0 (fr)
SK (1) SK8062000A3 (fr)
TR (1) TR200002012T2 (fr)
TW (1) TW455590B (fr)
WO (1) WO1999032431A1 (fr)
ZA (1) ZA9811237B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
AR004691A1 (es) 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
WO1999032431A1 (fr) 1999-07-01
ZA9811237B (en) 1999-07-19
HUP0004428A3 (en) 2002-04-29
AR017199A1 (es) 2001-08-22
IS5544A (is) 2000-06-21
CN1280559A (zh) 2001-01-17
CA2314989A1 (fr) 1999-07-01
SK8062000A3 (en) 2001-02-12
NO20003216L (no) 2000-06-21
EP1047663A1 (fr) 2000-11-02
TW455590B (en) 2001-09-21
KR20010033407A (ko) 2001-04-25
NO20003216D0 (no) 2000-06-21
AU1989299A (en) 1999-07-12
SE9704835D0 (sv) 1997-12-22
ID26940A (id) 2001-02-22
IL136829A0 (en) 2001-06-14
US6235792B1 (en) 2001-05-22
PL341525A1 (en) 2001-04-23
TR200002012T2 (tr) 2000-10-23
BR9814381A (pt) 2000-10-10
JP2001526254A (ja) 2001-12-18
HUP0004428A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
EE9900259A (et) Ühendi uus vorm
ATE233756T1 (de) Kristalline form von omeprazol-natriumsalz
IS5338A (is) Ný spíróasabísýklísk heterósýklísk efnasambönd
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
DE69812007D1 (de) Aliphatische Lösungen von Aminoalkyllithiumverbindungen
DK1028111T3 (da) Amidderivater eller salte heraf
EP1003514A4 (fr) Amines cycliques modulant l'activite des recepteurs de chimiokines
PT1027332E (pt) Novas lactamas inibidoras de metaloproteases
ID24455A (id) Alat untuk penyatuan-amorf pipa-pipa
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
PT958287E (pt) Inibidores de sulfamida-metaloprotease
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
AR017655A1 (es) Metodo para preparar eteres de monofluormetilo
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
EP0994707A4 (fr) Inhibiteurs de l'activite enzymatique de naaladase
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
EE9900549A (et) Uus sool
DK0928192T3 (da) Antimykotisk gel med høj frigivelse af aktivt stof
EE9600127A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
NO20000686D0 (no) Enantiomerer av 4-[[(cyanoimino)-[(1,2,2- trimetylpropyl)amino]metyl]amino]benzonitril
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
DE69811256D1 (de) Polymorphe modifikationen von dofetilid
EE200000384A (et) Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum